Ewa P. Malc

Ewa P. Malc

Auto-generated profile, based on publicly available information

Ewa P. Malc

Department of Genetics, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina, United States of America

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 October 2019 in Cell
Verified
Journal Article
Open access
DCDavid J. Clark
David J. Clark
SDSaravana M. Dhanasekaran
Saravana M. Dhanasekaran
FPFrancesca Petralia
Francesca Petralia
JPJianbo Pan
Jianbo Pan
XSXiaoyu Song
Xiaoyu Song
ZTZhidong Tu
Zhidong Tu
To elucidate the deregulated functional modules that drive clear cell renal cell carcinoma (ccRCC), we performed comprehensive genomic, epigenomic, transcriptomic, proteomic, and phosphoproteomic characterization of treatment-naive ccRCC and paired normal adjacent tissue samples. Genomic analyses identified a distinct molecular subgroup associated with genomic instability. Integration of proteogenomic measurements uniquely identified protein dysregulation of cellular mechanisms impacted by genomic alterations, including oxidative phosphorylation-related metabolism, protein translation processes, and phospho-signaling modules. To assess the degree of immune infiltration in individual tumors, we identified microenvironment cell signatures that delineated four immune-based ccRCC subtypes characterized by distinct cellular pathways. This study reports a large-scale proteogenomic analysis of ccRCC to discern the functional impact of genomic alterations and provides evidence for rational treatment selection stemming from ccRCC pathobiology.

1 May 2012 in Molecular Cell
Verified
Journal Article
Closed access
SRSteven A. Roberts
Steven A. Roberts
JSJoan Sterling
Joan Sterling
CTCole Thompson
Cole Thompson
SHShawn Harris
Shawn Harris
DMDeepak Mav
Deepak Mav
DGDmitry Gordenin
Dmitry Gordenin

1 February 2020 in Cell
Verified
Journal Article
Open access
YDYongchao Dou
Yongchao Dou
EKEmily A. Kawaler
Emily A. Kawaler
DZDaniel Cui Zhou
Daniel Cui Zhou
MGMarina A. Gritsenko
Marina A. Gritsenko
CHChen Huang
Chen Huang
GZGrace Zhao
Grace Zhao
We undertook a comprehensive proteogenomic characterization of 95 prospectively collected endometrial carcinomas, comprising 83 endometrioid and 12 serous tumors. This analysis revealed possible new consequences of perturbations to the p53 and Wnt/β-catenin pathways, identified a potential role for circRNAs in the epithelial-mesenchymal transition, and provided new information about proteomic markers of clinical and genomic tumor subgroups, including relationships to known druggable pathways. An extensive genome-wide acetylation survey yielded insights into regulatory mechanisms linking Wnt signaling and histone acetylation. We also characterized aspects of the tumor immune landscape, including immunogenic alterations, neoantigens, common cancer/testis antigens, and the immune microenvironment, all of which can inform immunotherapy decisions. Collectively, our multi-omic analyses provide a valuable resource for researchers and clinicians, identify new molecular associations of potential mechanistic significance in the development of endometrial cancers, and suggest novel approaches for identifying potential therapeutic targets.

10 August 2015 in Nature Genetics
Verified
Journal Article
Open access
PDF file
KCKin Chan
Kin Chan
SRSteven A Roberts
Steven A Roberts
LKLeszek J Klimczak
Leszek J Klimczak
JSJoan F Sterling
Joan F Sterling
NSNatalie Saini
Natalie Saini
DGDmitry Gordenin
Dmitry Gordenin
Dmitry Gordenin and colleagues use a yeast reporter strain to identify distinct mutagenic signatures for the cytosine deaminases APOBEC3A and APOBEC3B. They find that cancer samples with APOBEC3A-like mutation signatures have greater than tenfold more APOBEC signature mutations than those with APOBEC3B-like signatures. Elucidation of mutagenic processes shaping cancer genomes is a fundamental problem whose solution promises insights into new treatment, diagnostic and prevention strategies1. Single-strand DNA–specific APOBEC cytidine deaminase(s) are major source(s) of mutation in several cancer types2,3,4. Previous indirect evidence implicated APOBEC3B as the more likely major mutator deaminase, whereas the role of APOBEC3A is not established5,6. Using yeast models enabling the controlled generation of long single-strand genomic DNA substrates7, we show that the mutation signatures of APOBEC3A and APOBEC3B are statistically distinguishable. We then apply three complementary approaches to identify cancer samples with mutation signatures resembling either APOBEC. Strikingly, APOBEC3A-like samples have over tenfold more APOBEC-signature mutations than APOBEC3B-like samples. We propose that APOBEC3A-mediated mutagenesis is much more frequent because APOBEC3A itself is highly proficient at generating DNA breaks8,9,10, whose repair can trigger the formation of single-strand hypermutation substrates.

1 February 2016 in Cell Reports
Verified
Journal Article
Open access
JHJames I. Hoopes
James I. Hoopes
LCLuis M. Cortez
Luis M. Cortez
TMTony M. Mertz
Tony M. Mertz
EMEwa P. Malc
Ewa P. Malc
PMPiotr Mieczkowski
Piotr Mieczkowski
SRSteven Roberts
Steven Roberts
APOBEC family cytidine deaminases have recently been implicated as powerful mutators of cancer genomes. How APOBECs, which are ssDNA-specific enzymes, gain access to chromosomal DNA is unclear. To ascertain the chromosomal ssDNA substrates of the APOBECs, we expressed APOBEC3A and APOBEC3B, the two most probable APOBECs mediating cancer mutagenesis, in a yeast model system. We demonstrate, using mutation reporters and whole genome sequencing, that APOBEC3A- and APOBEC3B-induced mutagenesis primarily results from the deamination of the lagging strand template during DNA replication. Moreover, our results indicate that both genetic deficiencies in replication fork-stabilizing proteins and chemical induction of replication stress greatly augment the mutagenesis of APOBEC3A and APOBEC3B. Taken together, these results strongly indicate that ssDNA formed during DNA lagging strand synthesis is a major substrate for APOBECs and may be the principal substrate in human cancers experiencing replication stress.

26 January 2015 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
ACAnders Ranegaard Clausen
Anders Ranegaard Clausen
SLScott A Lujan
Scott A Lujan
ABAdam B Burkholder
Adam B Burkholder
COClinton D Orebaugh
Clinton D Orebaugh
JWJessica S Williams
Jessica S Williams
TKThomas Kunkel
Thomas Kunkel
HydEn-seq, a new sequencing method that maps the distribution of ribonucleotides misincorporated by low-fidelity DNA polymerases in budding yeast, reveals unexpected strand-specific replication patterns in both nuclear and mitochondrial genomes. Ribonucleotides are frequently incorporated into DNA during replication in eukaryotes. Here we map genome-wide distribution of these ribonucleotides as markers of replication enzymology in budding yeast, using a new 5′ DNA end–mapping method, hydrolytic end sequencing (HydEn-seq). HydEn-seq of DNA from ribonucleotide excision repair–deficient strains reveals replicase- and strand-specific patterns of ribonucleotides in the nuclear genome. These patterns support the roles of DNA polymerases α and δ in lagging-strand replication and of DNA polymerase ɛ in leading-strand replication. They identify replication origins, termination zones and variations in ribonucleotide incorporation frequency across the genome that exceed three orders of magnitude. HydEn-seq also reveals strand-specific 5′ DNA ends at mitochondrial replication origins, thus suggesting unidirectional replication of a circular genome. Given the conservation of enzymes that incorporate and process ribonucleotides in DNA, HydEn-seq can be used to track replication enzymology in other organisms.